These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4203986)

  • 1. [On the sensitivity to TUM-N of tubercle bacilli isolated from tuberculous patients who had never employed TUM-N--for determination of the critical concentration of TUM-N resistance (author's transl)].
    Toyoara M
    Kekkaku; 1973 Sep; 48(9):405-10. PubMed ID: 4203986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effects of antituberculous chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli (author's transl)].
    Uratsuji Y
    Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):20-9. PubMed ID: 99201
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibilities of advances in the determination of drug resistance of tubercle bacilli].
    Buraczewska M
    Gruzlica; 1971 Aug; 39(8):729-37. PubMed ID: 4999630
    [No Abstract]   [Full Text] [Related]  

  • 6. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
    Tsukamura M
    Kekkaku; 1978 Oct; 53(10):495-8. PubMed ID: 102861
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity to ethambutol and to capreomycin in wild strains of Tubercle bacilli isolated from patients previously untreated with these drugs.
    Blitek-Golc D; Zduńczyk-Pawelek H; Antosiewicz A
    Pol Med J; 1971; 10(4):945-51. PubMed ID: 5001656
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug activity of bleomycin against tubercle bacilli isolated from pulmonary tuberculous in-patients (author's transl)].
    Endo K
    Jpn J Antibiot; 1973 Dec; 26(6):501-3. PubMed ID: 4131340
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
    Kovalev GK
    Antibiotiki; 1969 Apr; 14(4):323-5. PubMed ID: 4977639
    [No Abstract]   [Full Text] [Related]  

  • 11. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
    Shimizu T
    Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacteriostatic effect of ethambutol on tubercle bacilli sensitive or resistant to other antitubercular drugs. A modification of the vertical diffusion method for determination of biologically active ethambutol].
    Strupczewska-Januszowa H; Grzymska L; Zwolińska G
    Gruzlica; 1969 Jul; 37(7):623-8. PubMed ID: 4981782
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of the susceptibility to major and minor drugs of tubercle bacilli isolated from 100 consecutive patients never treated with minor drugs.
    Tan THIAM HOK ; The KIE SENG ; Yang SHE YEN ; Tan LIOE SAN
    Paediatr Indones; 1966; 6(2):71-4. PubMed ID: 4960067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental studies in vitro on the antituberculous activities of tuberactinomycin (TUM) and tuberactinomycin-N (TUM-N) (author's transl)].
    Maekawa N; Ikeda N; Oda Y; Uratsuji Y; Inagake H
    Kekkaku; 1977 May; 52(5):211-8. PubMed ID: 407391
    [No Abstract]   [Full Text] [Related]  

  • 16. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiology of primary drug resistance in tuberculosis in the Federal Republic of Germany including Berlin (West) during 1972 to 1975 (author's transl)].
    Matthiessen W; Kind A; Göbel D
    Prax Klin Pneumol; 1977 Oct; 31(10):890-8. PubMed ID: 412177
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on cross-resistance between isoniazid, isoxyl, teebazone, ethionamide and ethambutol of tubercle bacilli from patients never treated with those drugs except with isoniazid.
    Tan TH; The KS; Yang SY; Tan LS; Ko HL; Tjie HB; Chatim A
    Paediatr Indones; 1966; 6(1):32-8. PubMed ID: 4959380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on the chemo-antibiotic-resistance in vitro of more than 400 strains of Mycobacterium tuberculosis recently isolated].
    Spaziante G; Caroli G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):512-34. PubMed ID: 4967921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.